A bibliometric research based on hotspots and frontier trends of denosumab

• প্রধান লেখক: Bolin Ren (লেখক), Xiaolei Ren (লেখক), Lu Wang (লেখক), Chao Tu (লেখক), Wenchao Zhang (লেখক), Zhongyue Liu (লেখক), Lin Qi (লেখক), Lu Wan (লেখক), Ke Pang (লেখক), Cheng Tao (লেখক), Zhihong Li (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Denosumab is a monoclonal antibody that targets and inhibits the osteoclast activating factor receptor activator for nuclear factor-κB ligand (RANKL). It has been widely used in the treatment of osteoporosis, giant cell tumors of bone, and in the prevention of malignant skeletal-related events (SREs...